Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Aiqun LiJiawei Zhou

Abstract

Apomorphine (APO), a potent D1/D2 dopamine receptor agonist, is currently used as an antiparkinsonian drug. We have shown previously that APO stimulates synthesis and release of multiple trophic factors, such as brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF), in both mesencephalic and striatal neurons, thereby effectively preventing dopaminergic neuron loss in vitro. The present study was designed to investigate the effects of APO on fibroblast growth factor-2 (FGF-2) expression and regulation in astrocytes, and furthermore, to identify signaling mechanisms underlying these effects. Here, we show that FGF-2 expression is robustly induced in cultured astrocytes in response to APO. FGF-2 expression was proportional to APO concentration and time-dependent. Conversely, treatment with S-APO, a derivative of R-APO lacking DA receptor agonist activity, did not alter FGF-2 levels. APO treatment resulted in enhanced cytosol FGF-2 immunoreactivity, export of high MW forms of FGF-2 to the cytoplasm from the nucleus and increased extracellular release of FGF-2. Interestingly, both high and low MW forms of FGF-2 were detectable in conditioned medium of APO-treated cultures. This APO-induced e...Continue Reading

References

Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R Z Florkiewicz, A Sommer
Mar 1, 1995·Journal of Cellular Physiology·R Z FlorkiewiczE Florkiewicz
Mar 14, 1997·The Journal of Biological Chemistry·R S PiotrowiczE G Levin
Feb 11, 1998·Physiological Reviews·C MissaleM G Caron
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·Z YanP Greengard
Jun 29, 2000·Biochemical and Biophysical Research Communications·M OhtaS Kuno
Jul 27, 2001·Current Opinion in Neurology·M VilaS Przedborski
Jul 24, 2002·Archives of Pharmacal Research·Choon-Gon JangDong-Keun Song
Nov 28, 2002·The European Journal of Neuroscience·Hong GuoJiawei Zhou
Jul 8, 2003·Cell and Tissue Research·Bernhard Reuss, Oliver von Bohlen und Halbach
Aug 28, 2003·Journal of Anti-aging Medicine·Marios Kyriazis
Oct 3, 2003·The Journal of Biological Chemistry·Simona TavernaMaria Letizia Vittorelli
May 19, 2004·Archives of Neurology·Jean-Antoine Girault, Paul Greengard
Aug 13, 2004·The European Journal of Neuroscience·Jiansong ShengJiawei Zhou

❮ Previous
Next ❯

Citations

Oct 14, 2008·Cellular and Molecular Life Sciences : CMLS·K ChlebovaP Krejci
Apr 2, 2009·BMC Pharmacology·Lin JiangEva Lindholm Carlström
Nov 21, 2013·Cellular and Molecular Neurobiology·Meng WangDianshuai Gao
Jan 19, 2011·The Journal of Physiology·Yevgenij YanovskyOlga A Sergeeva
Jun 1, 2011·The EPMA Journal·Paola MoralesEdgardo Rojas-Mancilla
Oct 1, 2008·Progress in Neurobiology·Ana SaavedraEmília P Duarte
Jul 19, 2008·Neuropharmacology·Francesca VagliniGiovanni U Corsini
Apr 22, 2015·Neurochemical Research·Kjell FuxeDasiel O Borroto-Escuela
Jun 17, 2008·Neuroscience Letters·Keiko ImamuraKenji Nakashima
Mar 4, 2008·Biochemical and Biophysical Research Communications·Xiaochun HeJiawei Zhou
Jul 11, 2008·The Journal of Comparative Neurology·Richa B Tripathi, Dana M McTigue
Mar 6, 2010·Annals of the New York Academy of Sciences·Catherine M Davis, Anthony L Riley
Dec 27, 2008·Biochimica Et Biophysica Acta·Rosario DonatoIleana Giambanco
Jan 1, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Naoki TakamuraIchiro Kusumi
Nov 19, 2011·Stroke; a Journal of Cerebral Circulation·Karsten RuscherTadeusz Wieloch
May 9, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Samo Ribarič
May 15, 2007·Journal of Neuroscience Research·Albert Cheung Hoi YuJi Sheng Han
Sep 13, 2007·American Journal of Physiology. Endocrinology and Metabolism·Carolina CristinaDamasia Becu-Villalobos
Jul 24, 2018·Frontiers in Synaptic Neuroscience·Annette Gower, Mario Tiberi
Apr 22, 2017·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Xiao ChenYu-Ping Peng
Jan 25, 2019·Translational Neurodegeneration·Shen-Zhao LuJia-Wei Zhou
Aug 26, 2018·The European Journal of Neuroscience·Oren Even-Chen, Segev Barak
Dec 11, 2020·Cells·Ikuko Miyazaki, Masato Asanuma
Aug 21, 2021·Cellular and Molecular Neurobiology·Tony HeurtauxMichel Mittelbronn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.